Secondary Prevention of Stroke in the Elderly: Focus on Drug Therapy

被引:13
作者
Arnan, Martinson K. [1 ]
Burke, Gregory L. [2 ]
Bushnell, Cheryl [1 ]
机构
[1] Wake Forest Univ Hlth Sci, Dept Neurol, Winston Salem, NC 27157 USA
[2] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Winston Salem, NC 27157 USA
关键词
TRANSIENT ISCHEMIC ATTACK; ISOLATED SYSTOLIC HYPERTENSION; DENSITY-LIPOPROTEIN-CHOLESTEROL; PROTHROMBIN COMPLEX CONCENTRATE; PAROXYSMAL ATRIAL-FIBRILLATION; AMERICAN-HEART-ASSOCIATION; SHORT-TERM PROGNOSIS; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE;
D O I
10.1007/s40266-014-0212-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Secondary stroke prevention in the elderly in many cases requires the use of drug therapy to maximize risk factor control. However, the elderly (>= 65 years) are most likely to receive care that is not evidence-based, because of concerns for adverse events. In this review, we provide evidence to the practitioner in support of the value of blood pressure control with drug therapy to decrease recurrent stroke risk. This review also highlights evidence for the importance of statin therapy in stroke prevention among the elderly. Finally, the appropriate use of antiplatelet therapy and oral anticoagulation is addressed.
引用
收藏
页码:721 / 730
页数:10
相关论文
共 123 条
[1]   Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis [J].
Amarenco, P ;
Labreuche, J ;
Lavallée, P ;
Touboul, PJ .
STROKE, 2004, 35 (12) :2902-2909
[2]   High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review [J].
Amarenco, Pierre ;
Labreuche, Julien ;
Touboul, Pierre-Jean .
ATHEROSCLEROSIS, 2008, 196 (02) :489-496
[3]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549
[4]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[5]  
[Anonymous], 1991, JAMA, V265, P3255
[6]   Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study [J].
Banerjee, Amitava ;
Lane, Deirdre A. ;
Torp-Pedersen, Christian ;
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) :584-589
[7]   J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial† [J].
Bangalore, Sripal ;
Messerli, Franz H. ;
Wun, Chuan-Chuan ;
Zuckerman, Andrea L. ;
DeMicco, David ;
Kostis, John B. ;
LaRosa, John C. .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2897-2908
[8]   Treatment of hypertension in patients 80 years of age or older [J].
Beckett, Nigel S. ;
Peters, Ruth ;
Fletcher, Astrid E. ;
Staessen, Jan A. ;
Liu, Lisheng ;
Dumitrascu, Dan ;
Stoyanovsky, Vassil ;
Antikainen, Riitta L. ;
Nikitin, Yuri ;
Anderson, Craig ;
Belhani, Alli ;
Forette, Francoise ;
Rajkumar, Chakravarthi ;
Thijs, Lutgarde ;
Banya, Winston ;
Bulpitt, Christopher J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18) :1887-1898
[9]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[10]   Hypertension in the Very Elderly Trial (HYVET) - Protocol for the Main Trial [J].
Bulpitt, C ;
Fletcher, A ;
Beckett, N ;
Coope, J ;
Gil-Extremera, B ;
Forette, F ;
Nachev, C ;
Potter, J ;
Sever, P ;
Staessen, J ;
Swift, C ;
Tuomilehto, J .
DRUGS & AGING, 2001, 18 (03) :151-164